» Articles » PMID: 26071920

Timing of Treatment Initiation for Mild Gestational Diabetes Mellitus and Perinatal Outcomes

Abstract

Objective: The purpose of this study was to examine the association between gestational age (GA) at the time of treatment initiation for gestational diabetes mellitus (GDM) and maternal and perinatal outcomes.

Study Design: We conducted a secondary analysis of a multicenter randomized treatment trial of mild GDM in which women with mild GDM were assigned randomly to treatment vs usual care. The primary outcome of the original trial, as well as this analysis, was a composite perinatal adverse outcome that included neonatal hypoglycemia, hyperbilirubinemia, hyperinsulinemia, and perinatal death. Other outcomes that were examined included the frequency of large for GA, birthweight, neonatal intensive care unit admission, gestational hypertension/preeclampsia, and cesarean delivery. The interaction between GA at treatment initiation (stratified as 24-26, 27, 28, 29, and ≥30 weeks of gestation) and treatment group (treated vs routine care), with the outcomes of interest, was used to determine whether GA at treatment initiation was associated with outcome differences.

Results: Of 958 women whose cases were analyzed, those who initiated treatment at an earlier GA did not gain an additional treatment benefit compared with those who initiated treatment at a later GA (probability value for interaction with the primary outcome, .44). Similarly, there was no evidence that other outcomes were improved significantly by earlier initiation of GDM treatment (large for GA, P = .76; neonatal intensive care unit admission, P = .8; cesarean delivery, P = .82). The only outcome that had a significant interaction between GA and treatment was gestational hypertension/preeclampsia (P = .04), although there was not a clear cut GA trend where this outcome improved with treatment.

Conclusion: Earlier initiation of treatment of mild GDM was not associated with stronger effect of treatment on perinatal outcomes.

Citing Articles

The relationship between timing of screening for gestational diabetes mellitus and maternal and fetal outcomes: A retrospective cohort study linking primary care electronic and hospital administrative data.

Piccinini-Vallis H, Grandy M, Bussey L, Coolen J, Sabri S Obes Pillars. 2025; 13:100159.

PMID: 39896975 PMC: 11786742. DOI: 10.1016/j.obpill.2025.100159.


Comparison of Maternal and Neonatal Outcomes Among High-Risk Filipino Women With Gestational Diabetes Diagnosed Before and After 24 Weeks of Gestation.

Dy K, Yao C J ASEAN Fed Endocr Soc. 2022; 37(2):9-14.

PMID: 36578893 PMC: 9758549. DOI: 10.15605/jafes.037.02.05.


Fetal abdominal overgrowth is already present at 20-24 gestational weeks prior to diagnosis of gestational diabetes mellitus.

Kim W, Park S, Kim Y Sci Rep. 2021; 11(1):23821.

PMID: 34893662 PMC: 8664824. DOI: 10.1038/s41598-021-03145-7.


Fetal Abdominal Obesity Detected At 24 to 28 Weeks of Gestation Persists Until Delivery Despite Management of Gestational Diabetes Mellitus.

Kim W, Park S, Kim Y Diabetes Metab J. 2021; 45(4):547-557.

PMID: 33663202 PMC: 8369219. DOI: 10.4093/dmj.2020.0078.


Identifying risk effectors involved in neonatal hypoglycemia occurrence.

Zhao T, Liu Q, Zhou M, Dai W, Xu Y, Kuang L Biosci Rep. 2020; 40(3).

PMID: 32083294 PMC: 7070145. DOI: 10.1042/BSR20192589.


References
1.
Alexander G, Kogan M, Himes J . 1994-1996 U.S. singleton birth weight percentiles for gestational age by race, Hispanic origin, and gender. Matern Child Health J. 2000; 3(4):225-31. DOI: 10.1023/a:1022381506823. View

2.
Nahum G, Wilson S, Stanislaw H . Early-pregnancy glucose screening for gestational diabetes mellitus. J Reprod Med. 2002; 47(8):656-62. View

3.
Crowther C, Hiller J, Moss J, McPhee A, Jeffries W, Robinson J . Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005; 352(24):2477-86. DOI: 10.1056/NEJMoa042973. View

4.
Metzger B, Coustan D . Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998; 21 Suppl 2:B161-7. View

5.
Metzger B, Lowe L, Dyer A, Trimble E, Chaovarindr U, Coustan D . Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008; 358(19):1991-2002. DOI: 10.1056/NEJMoa0707943. View